Shankar Siva
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V, Putora P, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L, Lamanna G, Koutsouvelis N, Dipasquale G, Ost P, Meersschout S, Guckenberger M, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte F, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Zilli T. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiother Oncol 2022; 172:1-9.
Apr 26, 2022Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Apr 26, 2022Radiother Oncol 2022; 172:1-9
Achard Vérane, Putora Paul Martin, Zwahlen Daniel, Couñago Felipe, Scorsetti Marta, Eito Clara, Barrado Marta, Zapatero Almudena, Muto Paolo, Van De Voorde Lien, Lamanna Giorgio, Koutsouvelis Nikolaos, Dipasquale Giovanna, Ost Piet, Meersschout Sabine, Guckenberger Matthias, Jaccard Maud, Vanhoutte Frederik, Siva Shankar, Heikkilä Reino, Dirix Piet, Liefhooghe Nick, Otte François-Xavier, Gomez-Iturriaga Alfonso, Berghen Charlien, Shelan Mohamed, Conde-Moreno Antonio, López Campos Fernando, Papachristofilou Alexandros, Zilli Thomas
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
Kroeze S, Schymalla M, Abbasi-Senger N, Buergy D, Geier M, Szuecs M, Lohaus F, Henke G, Combs S, Stera S, Adebahr S, Sundahl N, Fritz C, Schaule J, Blanck O, Kahl K, Kaul D, Siva S, Gerum S, Claes A, Guckenberger M. Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis. Cancers (Basel) 2021; 13
Sep 24, 2021Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
Sep 24, 2021Cancers (Basel) 2021; 13
Kroeze Stephanie G C, Schymalla Markus M, Abbasi-Senger Nasrin, Buergy Daniel, Geier Michael, Szuecs Marcella, Lohaus Fabian, Henke Guido, Combs Stephanie E, Stera Susanne, Adebahr Sonja, Sundahl Nora, Fritz Corinna, Schaule Jana, Blanck Oliver, Kahl Klaus Henning, Kaul David, Siva Shankar, Gerum Sabine, Claes An, Guckenberger Matthias
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Kroeze S, Eckert F, Lohaus F, Sackerer I, Skazikis G, Geier M, Szuecs M, Glatzer M, Schymalla M, Adebahr S, Verhoeff J, Siva S, Roeder F, Kahl K, Blanck O, Kaul D, Fritz C, Schaule J, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
Jan 6, 2021Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Jan 6, 2021Radiat Oncol 2021; 16:4
Kroeze Stephanie G C, Eckert Franziska, Lohaus Fabian, Sackerer Irina, Skazikis Georgios, Geier Michael, Szuecs Marcella, Glatzer Markus, Schymalla Markus M, Adebahr Sonja, Verhoeff Joost J C, Siva Shankar, Roeder Falk, Kahl Klaus H, Blanck Oliver, Kaul David, Fritz Corinna, Schaule Jana, Guckenberger Matthias